Search research articles
Contact Us
Filters
Showing results (251-260 of 275) with videos related to
Page
of 28
Sort By:
The Lancet. Infectious Diseases
|
December 24, 2017
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial
Benoit Guery, Francesco Menichetti, Veli-Jukka Anttila, et al.
United European Gastroenterology Journal
|
December 17, 2019
Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug
Josbert J Keller, Maria Jgt Vehreschild, Christian L Hvas, et al.
United European Gastroenterology Journal
|
March 28, 2020
Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are needed
Josbert J Keller, Maria Jgt Vehreschild, Christian L Hvas, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
July 24, 2021
Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons Learned
Ali Mansour, Andrea Loggini, Faten El Ammar, et al.
The Journal of Infection
|
May 18, 2025
Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial
Blair Merrick, Désirée Prossomariti, Elizabeth Allen, et al.
The Journal of Hospital Infection
|
July 5, 2024
The drainome: longitudinal metagenomic characterization of wastewater from hospital ward sinks to characterize the microbiome and resistome and to assess the effects of decontamination interventions
L B Snell, D Prossomariti, A Alcolea-Medina, et al.
Neurocritical Care
|
October 7, 2020
Cerebrovascular Complications in Early Survivors of Civilian Penetrating Brain Injury
Ali Mansour, Andrea Loggini, Faten El Ammar, et al.
The Journal of Infection
|
August 15, 2025
Erratum to "Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial" [J Infect 91 (2025) 106504]
Blair Merrick, Désirée Prossomariti, Elizabeth Allen, et al.
The Journal of Hospital Infection
|
September 4, 2018
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, et al.
Journal of Neurotrauma
|
March 10, 2026
AI-Aided Triage for GSWH: Validating an Interpretable HCT-Based Mortality Model
Ali Mansour, Jordan Fuhrman, Ronald Alvarado-Dyer, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 275) with videos related to
Sort By:
Page
of 28
The Lancet. Infectious Diseases
|
December 24, 2017
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial
Benoit Guery, Francesco Menichetti, Veli-Jukka Anttila, et al.
United European Gastroenterology Journal
|
December 17, 2019
Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug
Josbert J Keller, Maria Jgt Vehreschild, Christian L Hvas, et al.
United European Gastroenterology Journal
|
March 28, 2020
Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are needed
Josbert J Keller, Maria Jgt Vehreschild, Christian L Hvas, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
July 24, 2021
Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons Learned
Ali Mansour, Andrea Loggini, Faten El Ammar, et al.
The Journal of Infection
|
May 18, 2025
Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial
Blair Merrick, Désirée Prossomariti, Elizabeth Allen, et al.
The Journal of Hospital Infection
|
July 5, 2024
The drainome: longitudinal metagenomic characterization of wastewater from hospital ward sinks to characterize the microbiome and resistome and to assess the effects of decontamination interventions
L B Snell, D Prossomariti, A Alcolea-Medina, et al.
Neurocritical Care
|
October 7, 2020
Cerebrovascular Complications in Early Survivors of Civilian Penetrating Brain Injury
Ali Mansour, Andrea Loggini, Faten El Ammar, et al.
The Journal of Infection
|
August 15, 2025
Erratum to "Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial" [J Infect 91 (2025) 106504]
Blair Merrick, Désirée Prossomariti, Elizabeth Allen, et al.
The Journal of Hospital Infection
|
September 4, 2018
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, et al.
Journal of Neurotrauma
|
March 10, 2026
AI-Aided Triage for GSWH: Validating an Interpretable HCT-Based Mortality Model
Ali Mansour, Jordan Fuhrman, Ronald Alvarado-Dyer, et al.
Page
of 28